These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7751430)

  • 1. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension.
    Frishman WH; Burris JF; Mroczek WJ; Weir MR; Alemayehu D; Simon JS; Chen SY; Bryzinski BS
    J Clin Pharmacol; 1995 Feb; 35(2):182-8. PubMed ID: 7751430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose bisoprolol/hydrochlorothiazide: an option in first-line, antihypertensive treatment.
    Zachariah PK; Messerli FH; Mroczek W
    Clin Ther; 1993; 15(5):779-87. PubMed ID: 8269444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose combination treatment for hypertension versus single-drug treatment-bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: combined analysis of comparative studies.
    Prisant LM; Neutel JM; Papademetriou V; DeQuattro V; Hall WD; Weir MR
    Am J Ther; 1998 Sep; 5(5):313-21. PubMed ID: 10099075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide.
    Frishman WH; Bryzinski BS; Coulson LR; DeQuattro VL; Vlachakis ND; Mroczek WJ; Dukart G; Goldberg JD; Alemayehu D; Koury K
    Arch Intern Med; 1994 Jul; 154(13):1461-8. PubMed ID: 8018001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment.
    Prisant LM; Weir MR; Papademetriou V; Weber MA; Adegbile IA; Alemayehu D; Lefkowitz MP; Carr AA
    Am Heart J; 1995 Aug; 130(2):359-66. PubMed ID: 7631621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
    Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study between bisoprolol and metoprolol, combined with hydrochlorothiazide, as antihypertensive therapy].
    Unzueta Montoya A; Unzueta A; Ordóñez Toquero G; Villasis Keever MA; Cocoletzi López J; Medina Santillán R
    Arch Inst Cardiol Mex; 2000; 70(6):589-95. PubMed ID: 11255718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension.
    Benetos A; Consoli S; Safavian A; Dubanchet A; Safar M
    Am Heart J; 2000 Oct; 140(4):E11. PubMed ID: 11011336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical results with bisoprolol 2.5 mg/hydrochlorothiazide 6.25 mg combination in systolic hypertension in the elderly.
    Benetos A; Adamopoulos C; Argyriadis P; Bean K; Consoli S; Safar M
    J Hypertens Suppl; 2002 Feb; 20(1):S21-5. PubMed ID: 11996196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group.
    Chrysant SG
    Arch Intern Med; 1994 Apr; 154(7):737-43. PubMed ID: 8147677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose combination therapy as first-line hypertension treatment for blacks and nonblacks.
    Prisant LM; Neutel JM; Ferdinand K; Papademetriou V; DeQuattro V; Hall WD; Weir MR
    J Natl Med Assoc; 1999 Jan; 91(1):40-8. PubMed ID: 10063787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial.
    Zhu DL; Bays H; Gao P; Mattheus M; Voelker B; Ruilope LM
    Clin Ther; 2012 Jul; 34(7):1613-24. PubMed ID: 22717420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effectiveness of a very low fixed-dose combination of moexipril and hydrochlorothiazide.
    Chrysant SG; Stimpel M
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):384-90. PubMed ID: 9514183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilazapril plus hydrochlorothiazide: improved efficacy without reduced safety in mild to moderate hypertension. A double-blind placebo-controlled multicenter study of factorial design.
    Pordy RC
    Cardiology; 1994; 85(5):311-22. PubMed ID: 7850821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical trial evaluating the 24-hour effects of bisoprolol/hydrochlorothiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension.
    Lewin AJ; Lueg MC; Targum S; Cardenas P
    Clin Cardiol; 1993 Oct; 16(10):732-6. PubMed ID: 8222387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled trial comparing diltiazem, hydrochlorothiazide, and their combination in the therapy of essential hypertension.
    Pool PE; Applegate WB; Woehler T; Sandall P; Cady WJ
    Pharmacotherapy; 1993; 13(5):487-93. PubMed ID: 8247917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.